Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy.
Toepfer
M
M
Rommel
F
F
Sitter
T
T
Spannagl
M
M
Held
E
E
Schramm
W
W
Schiffl
H
H
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology / Q000302:isolation & purification*; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D005112:Extracorporeal Circulation; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D005169:Factor VIII